Intervacc AB
556238-1748ActiveDeveloping next-generation recombinant protein vaccines for animal health.
Overview
- 5–9
- Employees
- 1–2.5M SEK
- Revenue
- 1984
- Founded
Key Decision Makers
Jan Persson
CFO
Patrik Hellberg
CIO
Andrew Waller
CSO
Jonas Sohlman
CEO
+9 more contacts in Funnelfeedr
Description
Intervacc is a Swedish biotechnology company focused on advancing animal health. The core mission involves developing novel vaccines utilizing recombinant protein fusion technology. This modern approach aims to provide effective alternatives to conventional vaccines, minimizing severe side effects....
Tags
Keywords
Company Information
- Industry
- Veterinärverksamhet
- Legal Form
- Aktiebolag
- VAT Number
- SE556238174801
Decision Makers
13 contacts in FunnelfeedrJan Persson
CFO
Patrik Hellberg
CIO
Andrew Waller
CSO
Jonas Sohlman
CEO
Mathias Uhlen
Board Member
Lennart Johansson
Board Member
Emil Billbäck
Board Member
Camilla Ramfelt McCarthy
Board Member
Andreas Johansson
VP supply chain management
Lisen Bratt Fredricson
Board Member
Björn Odlander
Board Member
Håkan Björklund
Chairman of the board
Anna-Carin Lagerlöf
Director Sales & Marketing
Similar Companies
20 similar companies in FunnelfeedrNORD VACC LÄKEMEDEL AKTIEBOLAG
1–4 employeesDistributes and markets veterinary medicines and vaccines across Scandinavia.
SVANOVA AB
Developing innovative veterinary diagnostic solutions for animal health.
Omnia Biotech AB
0 employeesSwedish biotech developing nanoparticle products and diagnostic kits.
ZalVac AB
1–4 employeesZalVac develops robust vaccines against various bacterial strains.
AcroPharma AB (publ)
0 employeesDeveloping innovative preventive therapeutics for major human diseases.
Browse More
Intervacc AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo